Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by bionicjoeon Jun 17, 2019 1:08pm
52 Views
Post# 29832797

RE:RE:RE:RE:Can't Assume Any Patients Have Been Treated Yet

RE:RE:RE:RE:Can't Assume Any Patients Have Been Treated Yet
Bunge wrote:
Claridge wrote: So lolll ...

From the guy that couldn't even understand the basics of a clinical trial process!

From the guy that was repeatdly posting about a 1-2$/share while not even having a drug manufacturer, not even an Ph. 1b ITA, etc ...!

Always amazes me how this Bungee rates himself!

____________

Bunge - (6/17/2019 10:11:44 AM) 
RE:Can't Assume Any Patients Have Been Treated Yet
Normal (perceived) timelines have always been out the window with TLT.

 


Stop addressing me.

I did not say anything to you benny.

Many here value your "research" in spite of your belligerence and out of respect for them I haven't reported you for bullying and harassment... yet
Pretty close though.


I said it over the weekend. Nothing good will come of Claridge returning to post on this board. The guy has absolutely no respect for other posters. His arrogance and his ugly mouth got him booted and wiped under the bencro handle and here he is up to his old tricks again.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities